ROSEN, A LEADING NATIONAL FIRM, Encourages GSK plc Investors to Secure Counsel Before Important Deadline in Securities Class Action - GSK
Rosen Law Firm, a global investor rights law firm, reminds purchasers of American Depositary Receipts ("ADRs") of GSK plc (NYSE:GSK) between February 5, 2020 and August 14, 2022, both dates inclusive ...
GSK INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that GSK plc Stockholders Have Opportunity to Lead Class Action Lawsuit!
NEW YORK, NY / ACCESS Newswire / February 20, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, ...
The Harvard Crimson1d
Biopharma Giant GSK to Expand Research and Development Footprint in Cambridge
International biotechnology company GlaxoSmithKline is moving its vaccine and infectious disease research teams to Cambridge, ...
FiercePharma6d
With new FDA approval, GSK joins Pfizer in the 5-in-1 meningococcal vaccine ring
With the approval, GSK adds a key new option to its market-leading meningitis vaccine portfolio. In a phase 3 study, GSK's vaccine—given in two doses six months apart—showed immunological ...
pharmaphorum5d
GSK backs £50m Oxford University cancer vaccine programme
GSK has teamed up ... it could also lead to new targeted cancer medicines, according to the partners. The programme will be led by Professor Sarah Blagden in Oxford's Department of Oncology ...
Business Wire3d
GSK INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that GSK plc Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has bee ...
Reuters6d
US FDA approves GSK's combo meningococcal vaccine
The U.S. Food and Drug Administration approved British drugmaker GSK's (GSK.L), opens new tab combination vaccine to protect against meningococcal infection for use in people aged 10 through 25 ...
Le Lézard3d
PENMENVY, GSK's 5-in-1 Meningococcal Vaccine, Approved by US FDA to Help Protect Against MenABCWY
GSK plc (LSE/NYSE: GSK) today announced that the US Food and Drug Administration (FDA) has approved PENMENVY (Meningococcal Groups A, B, C, W, and Y Vaccine) for use in individuals aged 10 through 25 ...
pharmaphorum3d
GSK says new inhaler will help slash its carbon footprint
GSK has developed a new propellant technology for inhaler devices that drastically reduces their use of greenhouse gases, which perhaps surprisingly account for nearly half (49%) of the group’s ...
London Evening Standard6d
Celebrity 'used as bait in £100,000 romance fraud' at Oxford Street souvenir shop
Love-struck victims were duped into handing over £100,000 in cash at a souvenir shop in Oxford Street for a celebrity they believed they were dating, police have revealed. Two arrests have been ...
The Motley Fool UK6d
Here’s the dividend forecast for GSK shares through to 2026!
When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in. The content of this article is provided for information ...